These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3766902)

  • 1. Serum and urinary carnitine and organic acids in Reye syndrome and Reye-like syndrome.
    Sugimoto T; Nishida N; Woo M; Takeuchi T; Yasuhara A; Kobayashi Y; Sakane Y
    Brain Dev; 1986; 8(3):257-61. PubMed ID: 3766902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary dicarboxylic acids in Reye syndrome.
    Tonsgard JH
    J Pediatr; 1985 Jul; 107(1):79-84. PubMed ID: 4009343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carnitine palmitoyltransferase 2 deficiency: the time-course of blood and urinary acylcarnitine levels during initial L-carnitine supplementation.
    Hori T; Fukao T; Kobayashi H; Teramoto T; Takayanagi M; Hasegawa Y; Yasuno T; Yamaguchi S; Kondo N
    Tohoku J Exp Med; 2010 Jul; 221(3):191-5. PubMed ID: 20543534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carnitine status in Reye and Reye-like syndromes.
    Matsuda I; Ohtani Y
    Pediatr Neurol; 1986; 2(2):90-4. PubMed ID: 3508684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carnitine deficiency in inherited organic acid disorders and Reye syndrome.
    Sugiyama N; Kidouchi K; Kobayashi M; Wada Y
    Acta Paediatr Jpn; 1990 Aug; 32(4):410-6. PubMed ID: 2288224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal handling of carnitine in children with carnitine deficiency and hyperammonemia associated with valproate therapy.
    Matsuda I; Ohtani Y; Ninomiya N
    J Pediatr; 1986 Jul; 109(1):131-4. PubMed ID: 3088240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carnitine metabolism and urinary organic acid excretion in Reye's syndrome and salicylate intoxication.
    Takayanagi M; Kakinuma H; Yamamoto S; Nakajima H
    Acta Paediatr Jpn; 1990 Aug; 32(4):406-9. PubMed ID: 2288223
    [No Abstract]   [Full Text] [Related]  

  • 8. Carnitine deficiency, organic acidemias, and Reye's syndrome.
    Stumpf DA; Parker WD; Angelini C
    Neurology; 1985 Jul; 35(7):1041-5. PubMed ID: 3892364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and therapeutic implications of medium-chain acylcarnitines in the medium-chain acyl-coA dehydrogenase deficiency.
    Roe CR; Millington DS; Maltby DA; Bohan TP; Kahler SG; Chalmers RA
    Pediatr Res; 1985 May; 19(5):459-66. PubMed ID: 4000772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal presentation of ventricular tachycardia and a Reye-like syndrome episode associated with disturbed mitochondrial energy metabolism.
    Scaglia F; Scheuerle AE; Towbin JA; Armstrong DL; Sweetman L; Wong LJ
    BMC Pediatr; 2002 Dec; 2():12. PubMed ID: 12507404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary C6-C12 dicarboxylic acylcarnitines in Reye's syndrome.
    Tracey BM; Cheng KN; Rosankiewicz J; Stacey TE; Chalmers RA
    Clin Chim Acta; 1988 Jun; 175(1):79-87. PubMed ID: 3168285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent, familial Reye-like syndrome with a new complex amino and organic aciduria.
    Elpeleg ON; Christensen E; Hurvitz H; Branski D
    Eur J Pediatr; 1990 Jul; 149(10):709-12. PubMed ID: 2120061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C6-C10-dicarboxylic aciduria: investigations of a patient with riboflavin responsive multiple acyl-CoA dehydrogenation defects.
    Gregersen N; Wintzensen H; Christensen SK; Christensen MF; Brandt NJ; Rasmussen K
    Pediatr Res; 1982 Oct; 16(10):861-8. PubMed ID: 7145508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum free carnitine in medium chain acyl-CoA dehydrogenase deficiency.
    Bzduch V; Behulova D; Salingova A; Ponec J; Fabriciova K; Kozak L
    Bratisl Lek Listy; 2003; 104(12):405-7. PubMed ID: 15053333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum dicarboxylic acids in patients with Reye syndrome.
    Tonsgard JH
    J Pediatr; 1986 Sep; 109(3):440-5. PubMed ID: 3746531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic carnitine deficiency: benefit of oral carnitine supplements vs. persisting biochemical abnormalities.
    Duran M; de Klerk JB; Wadman SK; Scholte HR; Beekman RP; Jennekens FG
    Eur J Pediatr; 1984 Aug; 142(3):224-8. PubMed ID: 6468448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of urinary metabolites in patients with dicarboxylic aciduria for differential diagnosis.
    Shimizu N; Yamaguchi S; Orii T
    Acta Paediatr Jpn; 1994 Apr; 36(2):139-45. PubMed ID: 8203256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carnitine palmitoyl transferase I deficiency presenting as a Reye-like syndrome without hypoglycaemia.
    Vianey-Saban C; Mousson B; Bertrand C; Stamm D; Dumoulin R; Zabot MT; Divry P; Floret D; Mathieu M
    Eur J Pediatr; 1993 Apr; 152(4):334-8. PubMed ID: 8482285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carnitine prevents Reye-like syndrome in atypical carnitine deficiency.
    Matsubasa T; Ohtani Y; Miike T; Kitano A; Endo F; Matsuda I
    Pediatr Neurol; 1986; 2(2):80-4. PubMed ID: 3508683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medium chain acyl-CoA dehydrogenase deficiency.
    Touma EH; Charpentier C
    Arch Dis Child; 1992 Jan; 67(1):142-5. PubMed ID: 1739332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.